These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 11347115)

  • 21. [Ischemic heart diseases and lipid metabolism: a circulation specialist's viewpoint].
    Umemoto S; Matsuzaki M
    Nihon Naika Gakkai Zasshi; 2001 Oct; 90(10):2093-9. PubMed ID: 11769507
    [No Abstract]   [Full Text] [Related]  

  • 22. Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology).
    Esselstyn CB
    Am J Cardiol; 1999 Aug; 84(3):339-41, A8. PubMed ID: 10496449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of CH 13.437 in different types of hyperlipidemia.
    Harvengt C
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:298+. PubMed ID: 4559547
    [No Abstract]   [Full Text] [Related]  

  • 24. Lipids and prevention in coronary care.
    Betteridge DJ
    Trans Med Soc Lond; 1994-1995; 111():43-58. PubMed ID: 9156156
    [No Abstract]   [Full Text] [Related]  

  • 25. 60 years studying heart-disease risk.
    Levy D
    Nat Rev Drug Discov; 2008 Sep; 7(9):715. PubMed ID: 19172683
    [No Abstract]   [Full Text] [Related]  

  • 26. Correction to the FIELD study report.
    Keech A; Simes J; Barter P; Best J; Scott R; Taskinen MR;
    Lancet; 2006 Oct; 368(9545):1415. PubMed ID: 17055933
    [No Abstract]   [Full Text] [Related]  

  • 27. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 28. Hyperlipidemia. When does treatment make a difference?
    Wise GR; Schultz TT
    Postgrad Med; 1996 Jul; 100(1):138-49. PubMed ID: 8668612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of multiple risk factors on coronary artery disease: beyond total cholesterol. Introduction.
    Gotto AM
    Am J Cardiol; 1998 Nov; 82(9A):1Q-2Q. PubMed ID: 9819097
    [No Abstract]   [Full Text] [Related]  

  • 30. Currently available lipid-lowering agents.
    Levy RI
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():14-21. PubMed ID: 3134381
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic management of the dyslipidemic patient].
    Agence Française de Sécurité Sanitaire des Produits de Santé
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):70-5. PubMed ID: 11240406
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical significance of primary and secondary prevention trials with lipid-lowering therapy against coronary heart disease].
    Sakai N; Yamashita S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():365-73. PubMed ID: 11347096
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipids and their role in coronary heart disease: what they do and how to manage them.
    Pradka LR
    Nurs Clin North Am; 2000 Dec; 35(4):981-91. PubMed ID: 11072283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Coronary arteriosclerosis and lipid metabolism (hyperlipemia)].
    Nakamura H
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():69-74. PubMed ID: 12734955
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of hyperlipidemia in women.
    Basaria S; Dobs AS
    Int J Fertil Womens Med; 2000; 45(1):22-33. PubMed ID: 10721741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypolipidemic agents and their indication].
    Teramoto T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():559-65. PubMed ID: 11347132
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of halofenate on serum lipids.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP; Mays J
    Clin Pharmacol Ther; 1973; 14(3):358-65. PubMed ID: 4572798
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidemiology of hyperlipidaemias.
    Balaquer-Vintró I
    Przegl Lek; 1983; 40(5):413-20. PubMed ID: 6622740
    [No Abstract]   [Full Text] [Related]  

  • 39. Which lipid fraction is the target and how often should this be monitored?
    Thompson G
    Heart; 2010 Mar; 96(6):413-4. PubMed ID: 20299412
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical feature and treatment of the hyperlipidemia in the elderly].
    Ito H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():758-65. PubMed ID: 11347169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.